These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34474011)

  • 1. Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
    Karwath A; Bunting KV; Gill SK; Tica O; Pendleton S; Aziz F; Barsky AD; Chernbumroong S; Duan J; Mobley AR; Cardoso VR; Slater K; Williams JA; Bruce EJ; Wang X; Flather MD; Coats AJS; Gkoutos GV; Kotecha D;
    Lancet; 2021 Oct; 398(10309):1427-1435. PubMed ID: 34474011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
    Cleland JGF; Bunting KV; Flather MD; Altman DG; Holmes J; Coats AJS; Manzano L; McMurray JJV; Ruschitzka F; van Veldhuisen DJ; von Lueder TG; Böhm M; Andersson B; Kjekshus J; Packer M; Rigby AS; Rosano G; Wedel H; Hjalmarson Å; Wikstrand J; Kotecha D;
    Eur Heart J; 2018 Jan; 39(1):26-35. PubMed ID: 29040525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
    Kotecha D; Holmes J; Krum H; Altman DG; Manzano L; Cleland JG; Lip GY; Coats AJ; Andersson B; Kirchhof P; von Lueder TG; Wedel H; Rosano G; Shibata MC; Rigby A; Flather MD;
    Lancet; 2014 Dec; 384(9961):2235-43. PubMed ID: 25193873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
    Kotecha D; Gill SK; Flather MD; Holmes J; Packer M; Rosano G; Böhm M; McMurray JJV; Wikstrand J; Anker SD; van Veldhuisen DJ; Manzano L; von Lueder TG; Rigby AS; Andersson B; Kjekshus J; Wedel H; Ruschitzka F; Cleland JGF; Damman K; Redon J; Coats AJS;
    J Am Coll Cardiol; 2019 Dec; 74(23):2893-2904. PubMed ID: 31806133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
    Kotecha D; Flather MD; Altman DG; Holmes J; Rosano G; Wikstrand J; Packer M; Coats AJS; Manzano L; Böhm M; van Veldhuisen DJ; Andersson B; Wedel H; von Lueder TG; Rigby AS; Hjalmarson Å; Kjekshus J; Cleland JGF;
    J Am Coll Cardiol; 2017 Jun; 69(24):2885-2896. PubMed ID: 28467883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.
    Kotecha D; Manzano L; Krum H; Rosano G; Holmes J; Altman DG; Collins PD; Packer M; Wikstrand J; Coats AJ; Cleland JG; Kirchhof P; von Lueder TG; Rigby AS; Andersson B; Lip GY; van Veldhuisen DJ; Shibata MC; Wedel H; Böhm M; Flather MD;
    BMJ; 2016 Apr; 353():i1855. PubMed ID: 27098105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using machine learning to uncover heterogeneity of beta blocker response in heart failure.
    Tison GH
    Cell Rep Med; 2022 Jan; 3(1):100504. PubMed ID: 35106513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials.
    Fung JW; Chan SK; Yeung LY; Sanderson JE
    Eur J Heart Fail; 2002 Aug; 4(4):489-94. PubMed ID: 12167389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation.
    Mordi IR; Santema BT; Kloosterman M; Choy AM; Rienstra M; van Gelder I; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Metra M; Ng LL; Ouwerkerk W; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Voors AA; Lang CC
    Clin Res Cardiol; 2019 Jul; 108(7):797-805. PubMed ID: 30610382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
    Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
    Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of beta-blocker therapy in heart failure and atrial fibrillation.
    Fung JW; Yu CM; Kum LC; Yip GW; Sanderson JE
    Card Electrophysiol Rev; 2003 Sep; 7(3):236-42. PubMed ID: 14739721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting factors for omitting beta-blockers in patients with tachycardia-induced cardiomyopathy after successful catheter ablation for atrial fibrillation.
    Takami A; Kato M; Kotake Y; Okamura A; Tomomori T; Kawatani S; Yamamoto K
    Heart Vessels; 2024 Aug; 39(8):706-713. PubMed ID: 38446171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.
    Bedford J; Drikite L; Corbett M; Doidge J; Ferrando-Vivas P; Johnson A; Rajappan K; Mouncey P; Harrison D; Young D; Rowan K; Watkinson P
    Health Technol Assess; 2021 Nov; 25(71):1-174. PubMed ID: 34847987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.